2nd Annual Advanced API Convention
CPhI 2nd Annual Advanced API Convention will focus on the development of high quality API’s for the Indian pharma market
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
‘We hope bilateral pharmaceutical trade between the US and India will grow at or above 10 per cent’
The US-India Business Council (USIBC) led a Pharmaceutical & Biologics Executive Mission to Hyderabad and New Delhi late last…
‘We are estimating revenue of Rs 75 crores in 2016’
Indian clinical research organisations are witnessing a downshift and companies are learning from others
Pharmexcil organises series of initiatives during CPhI Japan
Brand India Pharma was strongly represented by Indian pharma companies at various platforms
Wockhardt recalls 12 drugs in US made at two India units
Wockhardt has decided to voluntarily recall all the remaining batches of 12-15 products that were manufactured in the Chikalthana…
US FDA public meeting on June 15 on reauthorisation of GDUFA
FDA has invited public suggestions on the GDUFA programme and the features FDA should propose for the next programme
NPPA threatens action against companies yet to register in IPDMS
More than half of top 100 pharma companies yet to register
US FDA nod for generics of Abilify
To market generic aripiprazole in multiple strengths and dosage forms to treat mental disorders
Rusan Pharma launches first ‘Made in India’ NRT patch 2baconil
Designed for humid climates; to co-partner with Brazilian govt in early May